DTSSP Crosslinker|CAS 81069-02-5|DC Chemicals

Cas No.:	81069-02-5
Chemical Name:	3,3'-Dithiobis(sulfosuccinimidylpropionate)
Synonyms:	3,3'-Dithiobis(sulfosuccinimidylpropionate);(SCH2CH2CONHC8H17)2;3,3'-disulfanediylbis(N-octylpropanamide);3,3'-dithiobis(N-octylpropionamide);3,3-dithiobis(sulfosuccinimidyl propionate);N,N'-Bis-n-octyl-3,3'-dithiopropionamide;N,N'-Di-n-octyl-3,3'-dithiodipropionamid;N,N'-di-n-octyl-3,3'-dithiodipropionamide;N,N'-dioctyl-3,3'-disulfanediyl-bis-propionamide;DTSSP;HY-126349;VOTJUWBJENROFB-UHFFFAOYSA-N;1,1'-((3,3'-Disulfanediylbis(propanoyl))bis(oxy))bis(2,5-dioxopyrrolidine-3-sulfonic acid);3,3'-Dithiobispropionic acid bis-sulfosuccinimidyl ester;C93510;1-[3-[3-(2,5-dioxo-3-sulfopyrrolidin-1-yl)oxy-3-oxopropyl]disulfanylpropanoyloxy]-2,5-dioxopyrrolidine-3-sulfonic acid;3,3'-Dithiobis(sulphosuccinimidyl propionate);MFCD01861949;3,3'-dithiobis(sulfosuccinimidyl propionate);DTXSID701001749;SCHEMBL243172;DTXSID30276271;AKOS015898342;Dtbssp;1-[3-[[3-(2,5-dioxo-3-sulfopyrrolidin-1-yl)oxy-3-oxopropyl]disulfanyl]propanoyloxy]-2,5-dioxopyrrolidine-3-sulfonic acid;3-Pyrrolidinesulfonic acid, 1,1'-(dithiobis((1-oxo-3,1-propanediyl)oxy))bis(2,5-dioxo-;81069-02-5;3-pyrrolidinesulfonic acid, 1,1'-[dithiobis[(1-oxo-3,1-propanediyl)oxy]]bis[2,5-dioxo-;85549-78-6;1,1'-{Disulfanediylbis[(1-oxopropane-3,1-diyl)oxy]}bis(2,5-dioxopyrrolidine-3-sulfonic acid);1-a[3-a[3-a?2,5-adioxo-a?-asulfopyrrolidin-a?-ayl)oxy-a?-aoxopropyl]disulfanylpropanoyloxy]-a?,5-adioxopyrrolidine-a?-asulfonic acid;3,3'-Dithiobispropionic Acid Bis-sulfosuccinimidyl Ester Disodium Salt 90%;DTSSP Crosslinker;CS-0102759;FT-0614095;1,1′-[Dithiobis[(1-oxo-3,1-propanediyl)oxy]]bis[2,5-dioxo-3-pyrrolidinesulfonic acid] (ACI);3,3′-Dithiobis(sulfosuccinimidyl propionate);bis(sulfosuccinimidyl) 3,3′-dithiobis(propionate)
SMILES:	O=C(CCSSCCC(ON1C(=O)C(S(O)(=O)=O)CC1=O)=O)ON1C(=O)C(S(O)(=O)=O)CC1=O
Formula:	C₁₄H₁₆N₂O₁₄S₄
M.Wt:	564.541839599609
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.